These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 10859301)
1. Amino acid identity and/or position determines the proteasomal cleavage of the HLA-A*0201-restricted peptide tumor antigen MAGE-3271-279. Miconnet I; Servis C; Cerottini JC; Romero P; Lévy F J Biol Chem; 2000 Sep; 275(35):26892-7. PubMed ID: 10859301 [TBL] [Abstract][Full Text] [Related]
2. The production of a new MAGE-3 peptide presented to cytolytic T lymphocytes by HLA-B40 requires the immunoproteasome. Schultz ES; Chapiro J; Lurquin C; Claverol S; Burlet-Schiltz O; Warnier G; Russo V; Morel S; Lévy F; Boon T; Van den Eynde BJ; van der Bruggen P J Exp Med; 2002 Feb; 195(4):391-9. PubMed ID: 11854353 [TBL] [Abstract][Full Text] [Related]
3. Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3. Valmori D; Gileadi U; Servis C; Dunbar PR; Cerottini JC; Romero P; Cerundolo V; Lévy F J Exp Med; 1999 Mar; 189(6):895-906. PubMed ID: 10075973 [TBL] [Abstract][Full Text] [Related]
4. The sequence alteration associated with a mutational hotspot in p53 protects cells from lysis by cytotoxic T lymphocytes specific for a flanking peptide epitope. Theobald M; Ruppert T; Kuckelkorn U; Hernandez J; Häussler A; Ferreira EA; Liewer U; Biggs J; Levine AJ; Huber C; Koszinowski UH; Kloetzel PM; Sherman LA J Exp Med; 1998 Sep; 188(6):1017-28. PubMed ID: 9743520 [TBL] [Abstract][Full Text] [Related]
5. Sequence signals for generation of antigenic peptides by the proteasome: implications for proteasomal cleavage mechanism. Altuvia Y; Margalit H J Mol Biol; 2000 Jan; 295(4):879-90. PubMed ID: 10656797 [TBL] [Abstract][Full Text] [Related]
6. Presentation assessment of minor histocompatibility antigens by predictive proteasomal cleavage analysis. Khattab B; Eiz-Vesper B; Ganser A; Hertenstein B; Blasczyk R Ann Hematol; 2004 Feb; 83(2):107-13. PubMed ID: 14648025 [TBL] [Abstract][Full Text] [Related]
7. Abrogation of CTL epitope processing by single amino acid substitution flanking the C-terminal proteasome cleavage site. Beekman NJ; van Veelen PA; van Hall T; Neisig A; Sijts A; Camps M; Kloetzel PM; Neefjes JJ; Melief CJ; Ossendorp F J Immunol; 2000 Feb; 164(4):1898-905. PubMed ID: 10657639 [TBL] [Abstract][Full Text] [Related]
8. Identification of a novel HLA-B60-restricted T cell epitope of the minor histocompatibility antigen HA-1 locus. Mommaas B; Kamp J; Drijfhout JW; Beekman N; Ossendorp F; Van Veelen P; Den Haan J; Goulmy E; Mutis T J Immunol; 2002 Sep; 169(6):3131-6. PubMed ID: 12218130 [TBL] [Abstract][Full Text] [Related]
9. Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma. Ayyoub M; Stevanovic S; Sahin U; Guillaume P; Servis C; Rimoldi D; Valmori D; Romero P; Cerottini JC; Rammensee HG; Pfreundschuh M; Speiser D; Lévy F J Immunol; 2002 Feb; 168(4):1717-22. PubMed ID: 11823502 [TBL] [Abstract][Full Text] [Related]
10. An antigenic peptide produced by peptide splicing in the proteasome. Vigneron N; Stroobant V; Chapiro J; Ooms A; Degiovanni G; Morel S; van der Bruggen P; Boon T; Van den Eynde BJ Science; 2004 Apr; 304(5670):587-90. PubMed ID: 15001714 [TBL] [Abstract][Full Text] [Related]
11. Effects of major-histocompatibility-complex-encoded subunits on the peptidase and proteolytic activities of human 20S proteasomes. Cleavage of proteins and antigenic peptides. Ehring B; Meyer TH; Eckerskorn C; Lottspeich F; Tampé R Eur J Biochem; 1996 Jan; 235(1-2):404-15. PubMed ID: 8631360 [TBL] [Abstract][Full Text] [Related]
12. An algorithm for the prediction of proteasomal cleavages. Kuttler C; Nussbaum AK; Dick TP; Rammensee HG; Schild H; Hadeler KP J Mol Biol; 2000 May; 298(3):417-29. PubMed ID: 10772860 [TBL] [Abstract][Full Text] [Related]
13. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Niedermann G; Butz S; Ihlenfeldt HG; Grimm R; Lucchiari M; Hoschützky H; Jung G; Maier B; Eichmann K Immunity; 1995 Mar; 2(3):289-99. PubMed ID: 7535183 [TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma can stimulate post-proteasomal trimming of the N terminus of an antigenic peptide by inducing leucine aminopeptidase. Beninga J; Rock KL; Goldberg AL J Biol Chem; 1998 Jul; 273(30):18734-42. PubMed ID: 9668046 [TBL] [Abstract][Full Text] [Related]
15. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. van der Bruggen P; Bastin J; Gajewski T; Coulie PG; Boël P; De Smet C; Traversari C; Townsend A; Boon T Eur J Immunol; 1994 Dec; 24(12):3038-43. PubMed ID: 7805731 [TBL] [Abstract][Full Text] [Related]
16. Final antigenic Melan-A peptides produced directly by the proteasomes are preferentially selected for presentation by HLA-A*0201 in melanoma cells. Chapatte L; Servis C; Valmori D; Burlet-Schiltz O; Dayer J; Monsarrat B; Romero P; Lévy F J Immunol; 2004 Nov; 173(10):6033-40. PubMed ID: 15528338 [TBL] [Abstract][Full Text] [Related]